CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

glycerol phenylbutyrate

Last Updated: August 2, 2016
Result type: Reports
Project Number: SR0497-000
Product Line: Reimbursement Review

Generic Name: glycerol phenylbutyrate

Brand Name: Ravicti

Manufacturer: Horizon Therapeutics Canada/Horizon Pharma Ireland Ltd.

Therapeutic Area: Urea cycle disorders

Indications: Urea cycle disorders

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: March 21, 2017

Recommendation Type: Reimburse with clinical criteria and/or conditions